India’s IVF ecosystem is entering a new era—one driven by artificial intelligence, precision medicine, and data-driven decision-making. As infertility rates rise and the demand for assisted reproductive technologies accelerates, IVF clinics are increasingly turning to advanced technologies to improve outcomes and patient confidence.
A significant step in this direction is the introduction of AI-powered embryo assessment, a breakthrough that is redefining how embryos are evaluated and selected for implantation.
A Strategic Collaboration Bringing Global Innovation to India
Hanahealth, the IVF vertical of DSS Imagetech, a leader in Molecular Diagnostics, Life Sciences, and Biotechnology, has partnered with Kai Health, a South Korea–based AI healthcare company, to bring its advanced embryo assessment solution, Vita Embryo, to IVF labs across India.
This collaboration reflects a shared commitment to innovation, technology integration, and elevating clinical standards in fertility treatment.
The Challenge of Traditional Embryo Selection
Embryo selection is one of the most critical steps in the IVF process. Traditionally, this evaluation relies heavily on the embryologist’s experience and visual assessment, making it inherently subjective and variable.
Subtle morphological differences that influence implantation potential may be difficult to detect with the human eye alone. This variability can impact success rates, prolong IVF cycles, and increase emotional and financial strain for patients.
How AI Is Changing Embryo Assessment
Vita Embryo, Kai Health’s AI-powered solution, addresses these challenges by supporting embryologists with greater accuracy, consistency, and transparency. Using advanced algorithms, the tool analyzes embryo images to identify key indicators of viability—many of which may be invisible to manual evaluation.
Clinical results have demonstrated that Vita Embryo’s AI can improve the accuracy of embryo selection by up to 25% compared to human evaluation alone.
By complementing clinical expertise rather than replacing it, AI helps IVF specialists make more informed, data-driven decisions.
Higher Implantation Success and Shorter IVF Cycles
The introduction of AI-powered embryo assessment enables IVF clinics to:
- Improve embryo selection precision
- Increase implantation success rates
- Reduce trial-and-error in embryo transfers
- Shorten IVF treatment cycles
- Enhance overall patient confidence and outcomes
“This collaboration aligns with DSS Imagetech’s focus on innovation, technology integration, and elevating clinical standards in IVF. Vita Embryo’s AI empowers embryologists to better predict embryo viability, reduce inefficiencies, and detect subtle embryo features invisible to the human eye. We expect a marked improvement in implantation success through this partnership,”
said A.R. Ghatak, VP – IVF Division, Hanahealth.
Empowering IVF Specialists Across India
India is one of the fastest-growing IVF markets globally, with the number of IVF cycles projected to double by 2030. Recognizing this potential, Kai Health aims to support India’s fertility ecosystem with globally validated AI solutions.
“By introducing our advanced AI-powered embryo selection tool, Vita Embryo, into Indian clinics, we aim to empower IVF specialists with more precise tools for embryo assessment—ultimately improving success rates and patient outcomes,”
said Dr Hyejun Lee, CEO & Founder, Kai Health.
Vita Embryo has already received medical device certification in multiple regions, including India, ensuring compliance with clinical and regulatory standards.
Early Adoption and Growing Momentum
The Vita Embryo solution is already being implemented by Nova IVF Fertility, India’s fastest-growing fertility chain with over 120 clinics nationwide. With promising early results, adoption is expected to expand rapidly across IVF clinics in India in the coming months.
The Future of IVF: Precision, Predictability, and Patient Trust
AI-powered embryo assessment represents a transformative shift in reproductive medicine. By reducing subjectivity and enhancing clinical insight, tools like Vita Embryo are helping IVF specialists deliver more predictable, efficient, and successful treatments.
As technology and medicine continue to converge, collaborations like the Hanahealth–Kai Health partnership are setting new benchmarks for IVF care in India—bringing hope, confidence, and better outcomes to countless families.
At The Doctorpreneur Academy, we help doctors build impact and authority using health education as a service.
👉 To register for our next masterclass, please click here: https://linktr.ee/docpreneur
